SSA
GLSI icon

Schonfeld Strategic Advisors’s Greenwich LifeSciences GLSI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17,800
Closed -$151K – 3046
2022
Q2 		$151K Buy
+17,800
New +$204K ﹤0.01% 2000

Other funds holding GLSI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Schonfeld Strategic Advisors's GLSI Position: Q3 2022 in Review

Schonfeld Strategic Advisors sold out of Greenwich LifeSciences (GLSI) in Q3 2022, closing a stake of 17,800 shares — an estimated $151K sold.

Schonfeld Strategic Advisors first reported a position in GLSI in Q2 2022 and held it in 1 quarter. The position peaked at $151K in Q2 2022. 21 funds tracked by Wall St. Rank hold GLSI as of Q3 2022.

  • Schonfeld Strategic Advisors reported no remaining Greenwich LifeSciences position as of Q3 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 17,800 Greenwich LifeSciences shares in Q3 2022, an estimated $151K.
  • Schonfeld Strategic Advisors first reported a position in Greenwich LifeSciences in Q2 2022 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Greenwich LifeSciences position peaked at $151K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.